SFG
NYMX

Steward Financial Group’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Steward Financial Group’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$0 Buy
+100
New +$24 ﹤0.01% 1628
2023
Q2 		– Sell
-100
Closed – – 1093
2023
Q1 		$0 Hold
100
– – ﹤0.01% 968
2022
Q4 		$0 Buy
+100
New +$36 ﹤0.01% 885
2022
Q3 		– Sell
-100
Closed – – 1454
2022
Q2 		$0 Hold
100
– – ﹤0.01% 1477
2022
Q1 		$0 Hold
100
– – ﹤0.01% 361
2021
Q4 		$0 Buy
+100
New +$160 ﹤0.01% 290

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return

Steward Financial Group's NYMX Position: Q3 2023 in Review

Steward Financial Group opened a new position in Nymox Pharmaceutical Corp (NYMX) in Q3 2023: 100 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1628 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in NYMX as recently as Q1 2023.

Steward Financial Group first reported a position in NYMX in Q4 2021 and has held it in 6 quarters since. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

  • Steward Financial Group held 100 shares of Nymox Pharmaceutical Corp worth $0 as of Q3 2023.
  • Nymox Pharmaceutical Corp was a new Steward Financial Group position in Q3 2023.
  • Nymox Pharmaceutical Corp made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1628 holding.
  • Steward Financial Group first reported a position in Nymox Pharmaceutical Corp in Q4 2021 and has held it in 6 quarters since.
  • 5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.